Friday, September 11, 2015


Fitwall Acquired By Skechers' Jeff Greenberg
Irvine-based fitness chain Fitwall has been acquired by Jeff Greenberg, the co-founder of Skechers, along with investor Jake Silverstein, the two said today. Financial details of the buy were not disclosed. The two said they now have a controlling stake in Fitwall, wiith Greenberg joining the company's board as Chairman. Greenberg was already an investor in Fitwall, which focuses on using technology like Bluetooth heart rate monitors and iPads to improve fitness.
posted on Friday, September 11, 2015(Full story)

NantOmics Buys OncoPlex Diagnostics
Los Angeles-based molecular diagnostics company NantOmics, which is one of the group of companies owned by biotech billionaire Patrick Soon Shiong, said Thursday that it has acquired OncoPlex Diagnostics, which is an accredited clinical laboratory focused on testing tumor cell proteins using mass spectrometry analysis. Financial termsd of the acquisition were not disclosed. NantWorks, the umbrella company for Soon Shiong's many ventures, already held a stack in OncoPlex, having first invested i (More info...)
posted on Friday, September 11, 2015(Full story)

Qualcomm Targets Consumer Drone Market With New Platform
San Diego-based Qualcomm has launched a new reference platform, specifically aimed at helping designers incorporate its chips into drone aircraft, the company said Thursday. According to Qualcomm, its subsidiary, Qualcomm Technologies, has launched a new reference platform called Qualcomm Snapdragon Flight, which is specifically aimed at use in consumer drones. The new platform offers up video and image capture, communications, navgiation, and a set of development tools, all aimed at integrating (More info...)
posted on Friday, September 11, 2015(Full story)

Orexigen Gets $60M In Private Placement
San Diego-based Orexigen Therapeutics, the publicly held biotech developer, said Thursday that it has raised $60M in a private placement. The funding came from The Baupost Group, LLC. Orexigenn Therapeutics said the new funding will go towards strengthening its balance sheet, ahead of commercial launch of its products. Orexigen said The Baupost Group purchased 5 million shares of its common stock at $3 per share, plus 0.25 of a warrant, which are exercisable for five years at $6 per share.
posted on Friday, September 11, 2015(Full story)

Iteris Signs Deal with Valent USA
Santa Ana-based transportation and agriculture information provider Iteris reported this week that it is in a deal with Valent U.S.A., to provide field-level weather, soil content, and crop protection via an API. According to Iteris, Valent is tapping into its ClearAg application programming interface, professional services, and more. Financial details of the deal were not disclosed. Valent provides products for agricultural crop protection and improviing crop yields, including herbicides, insec (More info...)
posted on Friday, September 11, 2015(Full story)